PANTHERx Specialty Pharmacy has been selected by Ultragenyx Pharmaceutical, Inc. to distribute Crysvita (burosumab-twza), the very first FDA-approved therapy for children and adults with x-linked hypophosphatemia (XLH). PANTHERx is one of a select few specialty pharmacies providing nationwide access to the medication. Crysvita (burosumab-twza) is the first drug approved to treat adults and children ages one year and older with…

PANTHERx Specialty Pharmacy has been selected by Otsuka America Pharmaceutical, Inc. to distribute Jynarque(tolvaptan), the only FDA-approved therapy for patients diagnosed with autosomal dominant polycystic kidney disease (ADPKD). PANTHERx is one of just three pharmacies providing nationwide access to the medication. ADPKD is one of the most common, life-threatening genetic diseases, diagnosed in 140,000 Americans. In patients with this condition,…